VCAM1 and glioblastoma: Our research has shown decreasing in VCAM-1 expression in GBM spheroids and also in U-87 MG glioblastoma cells to G721-0282 treatment, mainly at concentrations of 100 − 25 μM, which could be explained by VCAM-1/IL-1β dependence.